NASDAQ:ACON

Aclarion (ACON) Stock Price, News & Analysis

Aclarion logo
$1.34 -0.03 (-2.19%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$1.36 +0.02 (+1.87%)
As of 11/18/2026 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Aclarion Stock (NASDAQ:ACON)

Advanced

Key Stats

Today's Range
$1.33
▼
$1.38
50-Day Range
$1.34
▼
$2.94
52-Week Range
$1.33
▼
$9.36
Volume
7,380 shs
Average Volume
15,532 shs
Market Capitalization
$3.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.50
Consensus Rating
Hold

Company Overview

Aclarion is a healthcare technology company that develops tools to help physicians assess chronic low back pain. Its Nociscan platform combines magnetic resonance spectroscopy data with proprietary biomarkers and software analysis to help identify lumbar discs that may be contributing to a patient’s pain.

Nociscan is designed to complement standard MRI by providing additional information about disc chemistry. The company’s technology is intended to support clinical decision-making and help physicians evaluate treatment options; it does not replace a physician’s diagnosis or judgment.

Aclarion is headquartered in the United States and has developed Nociscan for use in clinical settings. The company focuses on expanding access to its platform and building clinical evidence for its use in evaluating patients with chronic low back pain.

AI Generated. May Contain Errors.

Aclarion Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

ACON MarketRank™: 
2.441685990995 of 5 stars

Aclarion scored higher than 49% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aclarion has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Aclarion has a consensus price target of $7.50, representing about 459.7% upside from its current price of $1.34.

  • Amount of Analyst Coverage

    Aclarion has only been the subject of 1 research reports in the past 90 days.

  • Read more about Aclarion's stock forecast and price target.
  • Earnings Growth

    Earnings for Aclarion are expected to decrease in the coming year, from ($4.51) to ($5.37) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aclarion is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aclarion is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Aclarion has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.75% of the float of Aclarion has been sold short.
  • Short Interest Ratio / Days to Cover

    Aclarion has a short interest ratio ("days to cover") of 1.62, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aclarion has recently decreased by 12.76%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Aclarion does not currently pay a dividend.

  • Dividend Growth

    Aclarion does not have a long track record of dividend growth.

    • Insider Buying vs. Insider Selling

      In the past three months, Aclarion insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      0.01% of the stock of Aclarion is held by insiders.

    • Percentage Held by Institutions

      7.52% of the stock of Aclarion is held by institutions.

    • Read more about Aclarion's insider trading history.
    Receive ACON Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Aclarion and its competitors with MarketBeat's FREE daily newsletter.

    SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    ACON Stock News Headlines

    Aclarion to Present at the 20th Annual LD Micro Main Event
    Your $7 scanner is waiting
    The Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.tc pixel
    See More Headlines

    ACON Stock Analysis - Frequently Asked Questions

    Aclarion's stock was trading at $4.60 at the beginning of the year. Since then, ACON stock has decreased by 70.9% and is now trading at $1.34.

    Aclarion, Inc. (NASDAQ:ACON) announced its quarterly earnings results on Thursday, November, 5th. The company reported ($0.94) earnings per share for the quarter, beating the consensus estimate of ($1.15) by $0.21. The company had revenue of $33.73 thousand for the quarter, compared to analysts' expectations of $32 thousand. Aclarion had a negative net margin of 10,215.15% and a negative trailing twelve-month return on equity of 62.91%.

    Aclarion's stock reverse split on the morning of Friday, March 28th 2025.The 1-27 reverse split was announced on Wednesday, March 26th 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

    Aclarion's board authorized a stock buyback plan on Wednesday, April 22nd 2026, which permits the company to repurchase $2.50 million in shares, according to EventVestor. This means that the company could repurchase up to 31% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board of directors believes its stock is undervalued.

    Aclarion (ACON) raised $12 million in an IPO on Friday, April 22nd 2022. The company issued 2,165,000 shares at $4.50-$6.50 per share.

    Shares of ACON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Aclarion investors own include D-Wave Quantum (QBTS), Tonix Pharmaceuticals (TNXP), Archer Aviation (ACHR), Actinium Pharmaceuticals (ATNM), Alibaba Group (BABA), Advanced Micro Devices (AMD) and Applied Therapeutics (APLT).

    Company Calendar

    Last Earnings
    11/05/2026
    Today
    11/18/2026
    Fiscal Year End
    12/31/2026

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Industry
    Healthcare Technology
    Sub-Industry
    Healthcare Technology
    Current Symbol
    NASDAQ:ACON
    CIK
    1635077
    Fax
    N/A
    Employees
    11
    Year Founded
    2008

    Price Target and Rating

    High Price Target
    $7.50
    Low Price Target
    $7.50
    Potential Upside/Downside
    +459.7%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    2 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($5.41)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$7.23 million
    Net Margins
    -10,215.15%
    Pretax Margin
    -10,216.16%
    Return on Equity
    -62.91%
    Return on Assets
    -59.33%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    14.17
    Quick Ratio
    14.17

    Sales & Book Value

    Annual Sales
    $80 thousand
    Price / Sales
    48.24
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $5.14 per share
    Price / Book
    0.26

    Miscellaneous

    Outstanding Shares
    2,880,000
    Free Float
    2,882,000
    Market Cap
    $3.86 million
    Optionable
    Not Optionable
    Beta
    1.21

    Social Links

    Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

    Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

    Get This Free Report

    This page (NASDAQ:ACON) was last updated on 11/18/2026 by MarketBeat.com Staff.
    From Our Partners